JOINT FILING AGREEMENT
Exhibit 99.3
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of ordinary shares of MediWound Ltd. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. In accordance with Rule 13d-1(k)(1), the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D and any amendments thereto with respect to the equity securities (as defined in Rule 13d-1(i)) of the issuer, beneficially owned by each of them. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13D and any amendments thereto.
This agreement may be executed in any number of counterparts, each of which shall be deemed an original.
Dated: March 17, 2022
| ACCESS INDUSTRIES HOLDINGS LLC | ||||||
| Access Industries Management, LLC, its Manager |
By: | /s/ Xxxxxxxxx Xxxxxx | ||||
| Name: | Xxxxxxxxx Xxxxxx | |||||
| Title: | Executive Vice President | |||||
| ACCESS INDUSTRIES MANAGEMENT, LLC | ||||||
| /s/ Xxxxxxxxx Xxxxxx | ||||||
| Name: | Xxxxxxxxx Xxxxxx | |||||
| Title: | Executive Vice President | |||||
| ACCESS INDUSTRIES, LLC | ||||||
| Access Industries Management, LLC, its Manager |
By: | /s/ Xxxxxxxxx Xxxxxx | ||||
| Name: | Xxxxxxxxx Xxxxxx | |||||
| Title: | Executive Vice President | |||||
| CLAL INDUSTRIES LTD. | ||||||
| By: | /s/ Yehuda Ben Ezra | |||||
| Name: | Yehuda Ben Ezra | |||||
| Title: | VP Comptroller | |||||
| By: | /s/ Nufar Malvani | |||||
| Name: | Nufar Malvani | |||||
| Title: | VP General Counsel & Corporate Secretary | |||||
15
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | ||
| By: | /s/ Xxxx Xxxxx | |
| Name: | Xxxx Xxxxx | |
| Title: | CEO | |
| By: | /s/ Xxxxx Xxxxx | |
| Name: | Xxxxx Xxxxx | |
| Title: | CFO | |
| CLAL LIFE SCIENCES L.P. | ||
| By: | /s/ Xxxx Xxxxx | |
| Name: | Xxxx Xxxxx | |
| Title: | Director | |
| By: | /s/ Xxxxx Xxxxx | |
| Name: | Xxxxx Xxxxx | |
| Title: | Director | |
| * | ||
| Name: | Xxx Xxxxxxxxx | |
| * | The undersigned, by signing his name hereto, executes this Schedule 13D pursuant to the Power of Attorney executed on behalf of Xx. Xxxxxxxxx and filed herewith. |
| By: | /s/ Xxxxxxxxx Xxxxxx | |
| Name: | Xxxxxxxxx Xxxxxx | |
| Attorney-in-Fact |
16
Annex A
| Name |
Directors and Officers of Clal Biotechnology Industries Ltd.
Principal Business/Occupation |
Citizenship | ||
| Xxxx Xxxxx | Chief Executive Officer of CBI | Israel | ||
| Xxxxx Xxxxx | Chief Financial Officer of CBI | Israel | ||
| Xxx Xxxxxxx | Chairman of CBI; Chairman and Chief Executive Officer of Clal Industries Ltd., the controlling shareholder of CBI; Chairman of Claltech Investments (2016) LLP; Chairman of Mashav Initiating and Development Ltd.; Chairman of Nesher Ltd.; Chairman of Clal Sun Ltd. | Israel | ||
| Xxxxx Xxxxx | Consulting and accompanying medical firms at Xxxxx Xxxxx Consulting and Management Ltd. | Israel | ||
| Xxxx. Xxxx Xxxxxxx | Chairman of Nara Medical Center Ltd.; Chief Executive of Consilium Isreal; Director, Bench to Bedside program, Weizmann Institute of Science, Israel | Israel | ||
| Prof. Gad Keren | Professor of Cardiology, Sackler School of Medicine, Tel Aviv University; Head of Cardiology department, Assuta | Israel | ||
| Xxxxxxx Xxxxxxx | Business consultant | Israel | ||
| Nufar Malovani | Vice President, General Counsel, Corporate Secretary and Human Resources Manager at Clal Industries Ltd. | Xxxxxx | ||
| Xxxxx Babai | Senior analyst at Clal Industries Ltd.; Vice President and United States of America of Claltech Investments (2016) LLP | Israel | ||
The address for each director and officer is c/o Clal Biotechnology Industries Ltd., 3 Azrieli Center Triangle Tower, 45 Floor, 132 Xxxxxxxx Xxxxx Xx. Xxx Xxxx 0000000, Xxxxxx.
17
